A systematic review and Bayesian network meta-analysis of medical therapies for lichen planopilaris

H Husein-ElAhmed, S Husein-ElAhmed - Dermatology, 2024 - karger.com
Background: Lichen planopilaris (LPP) is a primary chronic lymphocytic cutaneous disorder
that selectively destroys the hair follicles, resulting in scarring alopecia. Unfortunately …

Treatment modalities for lymphocytic and neutrophilic scarring alopecia

O Ezemma, S Devjani, KJ Kelley, MM Senna - Journal of the American …, 2023 - Elsevier
Primary cicatricial alopecia can result in permanent hair loss from the destruction of hair
follicles. Early intervention is key in controlling disease progression, reducing symptoms …

Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines

EC Siegfried, LM Arkin, YE Chiu, AA Hebert… - Pediatric …, 2023 - Wiley Online Library
Methotrexate (MTX) is a readily accessible drug, first used in 1948 and employed for a wide
variety of indications since then. However, despite widespread off‐label use, FDA labeling …

Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: A Retrospective Cohort Study

A Lyakhovitsky, T Zilbermintz, Z Segal, E Galili… - Dermatology, 2024 - karger.com
Introduction: Lichen planopilaris (LPP) is a common type of primary cicatricial alopecia.
Previous studies focused on the epidemiology, clinical characteristics, and treatment of LPP …

Clinical Effectiveness of Two Old Immunosuppressant Drugs, Methotrexate and Azathioprine, in the Treatment of Lichen Planopilaris: A Randomized Clinical Trial

M Saber, P Hajheidari, F Fatemi Naeini… - Dermatologic …, 2024 - Wiley Online Library
Background. Lichen planopilaris is the leading cause of cicatricial alopecia, and its
management is challenging for dermatologists. It is a cell‐mediated autoimmune disorder in …